Windtree shareholders approve all proposals at annual meeting, including equity issuances

WINDTREE THERAPEUTICS INC /DE/

Elected directors Fraser, Latkin, Pelletier, Strobeck with >258,000 votes each; broker non-votes 112,534.
Advisory say-on-pay approved: 252,693 for, 11,061 against, 8,795 abstentions, 112,534 broker non-votes.
Ratified EisnerAmper as 2024 auditor: 368,203 for, 7,737 against, 9,143 abstentions (no broker non-votes).
Approved share issuance under committed equity financing (255,211 for, 8,648 against) per Nasdaq Rule 5635(d).
Approved conversion of Series C Preferred (initial conv. price $3.74, floor $1.28) and warrant exercise ($4.11): 251,535 for.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.